Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 112 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1111 10.6 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
St James’s University Hospital United Kingdom 1/2014
Treatment Details: Patients: This phase 2 study involved advanced non-small cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 58 patients with an average age
 
1112 10.6 months Metastatic breast cancer 3 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 6/2014
Treatment Details: Patients: This phase 2 study involved 22 previously treated, metastatic breast cancer with a median age of 51 years (range 38-70). Treatment: Patients were treated with the biologic the
 
1113 10.6 months GBM 5 Chemotherapy
Radiation
Seoul National University College of Medicine Korea 4/2014
Treatment Details: Patients: This study involved 33 glioblastoma patients. The median patient age was 66 years and 55% were male. Treatment: Patients were treated with hypofractionated chemoradiotherapy
 
1114 10.6 months Malignant pleural mesothelioma 4 Biologic therapy
Netherlands Cancer Institute Netherlands 5/2013
Treatment Details: Patients: This phase 3 study involved 111 malignant pleural mesothelioma patients who had previously received chemotherapy that contained pemetrexed. The median patient age was 64 years an
 
1115 10.5 months BRAF-mutant metastatic melanoma 4 Chemotherapy
Institute Gustave Roussy France 6/2013
Treatment Details: Patients: This phase 2 study involved BRAF-mutant metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 45 patients with a median age of 57
 
1116 10.5 months Large cell lymphoma 4 St. Lukes-Roosevelt Hospital Center United States 6/2012
Treatment Details: Patients: This study involved 37 diffuse large cell lymphoma or large cell immunoblastic lymphoma patients who had received prior chemotherapy. The median patient age was 68 years and 41%
 
1117 10.5 months Advanced urothelial cancer 5 Biologic therapy
University of Michigan Comprehensive Cancer Center United States 11/2013
Treatment Details: Patients: This phase 2 study involved 26 previously treated advanced urothelial carcinoma patients. The median patient age was 69 years and 77% were male. Treatment: Patients were trea
 
1118 10.5 months Platinum-resistant ovarian cancer 5 Chemotherapy
Imperial College London United Kingdom 1/2014
Treatment Details: Patients: This phase 3 study involved platinum-resistant ovarian cancer patients who were separated into two treatment groups. Group A consisted of 70 women with a median age of 57.5 years
 
1119 10.5 months Advanced hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
Chiba University Japan 3/2014
Treatment Details: Patients: This phase 2 study involved 26 advanced hepatocellular carcinoma patients with an average age of 65.5 years; 88.5% were male. Treatment: Patients were treated with the chemoth
 
1120 10.5 months Recurrent malignant glioma 5 Biologic therapy
Kyorin University Faculty of Medicine Japan 7/2012
Treatment Details: Patients: This phase II study involved 31 patients with recurrent malignant glioma previously treated with temozolomide plus radiotherapy. The median age was 54 years; 51.6% were male.
 
Page 112 of 187  | Previous Page  | Next Page